Short Interest in F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC) Drops By 50.9%

F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC) was the target of a large decrease in short interest during the month of April. As of April 30th, there was short interest totaling 2,968 shares, a decrease of 50.9% from the April 15th total of 6,046 shares. Based on an average daily trading volume, of 3,055 shares, the days-to-cover ratio is currently 1.0 days. Approximately 0.1% of the shares of the stock are short sold.

F/m Emerald Life Sciences Innovation ETF Price Performance

Shares of LFSC stock traded down $1.27 on Friday, hitting $37.11. 962 shares of the company’s stock were exchanged, compared to its average volume of 4,824. F/m Emerald Life Sciences Innovation ETF has a 12 month low of $22.53 and a 12 month high of $40.10. The company has a 50 day moving average of $36.06 and a 200 day moving average of $36.06.

Institutional Trading of F/m Emerald Life Sciences Innovation ETF

A hedge fund recently raised its stake in F/m Emerald Life Sciences Innovation ETF stock. Hunter Associates Investment Management LLC increased its holdings in shares of F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC) by 13.1% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 45,908 shares of the company’s stock after buying an additional 5,312 shares during the quarter. Hunter Associates Investment Management LLC owned 1.81% of F/m Emerald Life Sciences Innovation ETF worth $1,684,000 at the end of the most recent reporting period.

About F/m Emerald Life Sciences Innovation ETF

The F/M Emerald Life Sciences Innovation ETF (LFSC) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed ETF that targets US health care and biotechnology companies identified to have promising life sciences opportunities. LFSC was launched on Oct 31, 2024 and is issued by F/m Investments.